Medivation Email Format

Pharmaceutical ManufacturingNew York, United States51-200 Employees

Medivation is a mid-sized pharmaceutical company focused on the rapid development of novel small molecule therapies for serious diseases that have limited treatment options. Its work seeks to transform treatment approaches and offer hope to critically ill patients and their families. A notable milestone in its history is the approval and launch of Xtandi (enzalutamide) capsules in 2012.

Founded in 2004 by a group of seasoned professionals with extensive experience in drug development, Medivation is based in New York City, New York. The company is presently part of Pfizer, Inc., reflecting a corporate transition that places its assets within a larger global pharmaceutical group.

Sign up for free to view info

Company overview Employee directory